T. Rowe Price Associates’s ALX Oncology ALXO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-10,622
| Closed | -$7K | – | 3061 |
|
|
2025
Q1 | $7K | Hold |
10,622
| – | – | ﹤0.01% | 3027 |
|
|
2024
Q4 | $18K | Hold |
10,622
| – | – | ﹤0.01% | 2987 |
|
|
2024
Q3 | $20K | Hold |
10,622
| – | – | ﹤0.01% | 2987 |
|
|
2024
Q2 | $65K | Sell |
10,622
-222,147
| -95% | -$1.36M | ﹤0.01% | 2820 |
|
|
2024
Q1 | $2.6M | Sell |
232,769
-310,474
| -57% | -$3.46M | ﹤0.01% | 1453 |
|
|
2023
Q4 | $8.09M | Buy |
+543,243
| New | +$8.09M | ﹤0.01% | 1134 |
|
|
2021
Q4 | – | Sell |
-4,110
| Closed | -$304K | – | 2975 |
|
|
2021
Q3 | $304K | Buy |
4,110
+44
| +1% | +$3.26K | ﹤0.01% | 2570 |
|
|
2021
Q2 | $222K | Sell |
4,066
-408
| -9% | -$22.3K | ﹤0.01% | 2684 |
|
|
2021
Q1 | $330K | Buy |
+4,474
| New | +$330K | ﹤0.01% | 2524 |
|
|
2020
Q4 | – | Sell |
-223,654
| Closed | -$8.44M | – | 2663 |
|
|
2020
Q3 | $8.44M | Buy |
+223,654
| New | +$8.44M | ﹤0.01% | 1332 |
|